Abstract
Purpose:
To assess if 1.5T MRI can be used to study the transport to the liver, the intrahepatic distribution and engraftment of iron‐oxide labelled hepatocytes in cyclophosphamide‐treated and untreated mice.
Materials and Methods:
Hepatocytes were isolated from C57bl/6 mice and were labelled with 1.63 μm iron‐oxide particles. Seventeen mice were pretreated with cyclophosphamide to disrupt the sinusoidal endothelium and 15 were left untreated. Seven days after splenic injection of the labelled hepatocytes, T2*‐weighted gradient‐echo images at 1.5T were acquired. The hepatic transport, distribution and engraftment of the labelled hepatocytes were assessed with signal intensity (SI) and T2* measurements, electron paramagnetic resonance (EPR), texture analysis and histology.
Results:
Lower hepatic SI (P = 0.005), lower T2* (P = 0.033) and larger number of particles at histology (P = 0.006) suggested increased transport to the liver of labelled hepatocytes in cyclophosphamide‐treated mice versus untreated mice. At histology, most particles were located in Kupffer cells. Particles distribution was heterogeneous. No difference between both groups was observed at texture analysis.
Conclusion:
MRI is useful to assess the transport to the liver and intrahepatic distribution of transplanted labelled hepatocytes. The preferential location of iron‐oxide particles within Kupffer cells after seven days limits the value of MRI for assessing hepatocyte engraftment. J. Magn. Reson. Imaging 2010;32:367–375. © 2010 Wiley‐Liss, Inc.